ZA916661B - Stabilized solid chemical compositions - Google Patents
Stabilized solid chemical compositionsInfo
- Publication number
- ZA916661B ZA916661B ZA916661A ZA916661A ZA916661B ZA 916661 B ZA916661 B ZA 916661B ZA 916661 A ZA916661 A ZA 916661A ZA 916661 A ZA916661 A ZA 916661A ZA 916661 B ZA916661 B ZA 916661B
- Authority
- ZA
- South Africa
- Prior art keywords
- water soluble
- alkaline stabilizer
- chemical compositions
- solid chemical
- stabilized solid
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Developing Agents For Electrophotography (AREA)
- Lubricants (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58185990A | 1990-09-13 | 1990-09-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA916661B true ZA916661B (en) | 1992-06-24 |
Family
ID=24326864
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA916661A ZA916661B (en) | 1990-09-13 | 1991-08-22 | Stabilized solid chemical compositions |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0475482B1 (de) |
JP (1) | JP3153577B2 (de) |
KR (1) | KR100196209B1 (de) |
AT (1) | ATE112491T1 (de) |
AU (1) | AU643920B2 (de) |
CA (1) | CA2049811C (de) |
DE (1) | DE69104453T2 (de) |
DK (1) | DK0475482T3 (de) |
ES (1) | ES2064887T3 (de) |
FI (1) | FI104361B (de) |
IE (1) | IE65274B1 (de) |
NZ (1) | NZ239753A (de) |
PT (1) | PT98955B (de) |
ZA (1) | ZA916661B (de) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU6428894A (en) * | 1993-03-26 | 1994-10-24 | Franciscus W.H.M. Merkus | Pharmaceutical compositions for intranasal administration of dihydroergotamine, apomorphine and morphine |
NZ501321A (en) * | 1997-03-26 | 2001-04-27 | Franciscus W | Nasal Melatonin composition |
GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
US6691057B2 (en) | 2001-02-26 | 2004-02-10 | L.U.M. Gesellschaft Fur Labor- Umweltdiagnostic & Medizintechnik Mbh | Method and device for accelerated stability analysis |
US7407955B2 (en) | 2002-08-21 | 2008-08-05 | Boehringer Ingelheim Pharma Gmbh & Co., Kg | 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions |
DE102004054054A1 (de) | 2004-11-05 | 2006-05-11 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine |
CA2491665A1 (fr) * | 2004-12-24 | 2006-06-24 | Louis Cartilier | Formulation de comprime pour liberation soutenue de principe actif |
EP1852108A1 (de) | 2006-05-04 | 2007-11-07 | Boehringer Ingelheim Pharma GmbH & Co.KG | Zusammensetzungen von DPP-IV-Inhibitoren |
PE20080251A1 (es) | 2006-05-04 | 2008-04-25 | Boehringer Ingelheim Int | Usos de inhibidores de dpp iv |
WO2007128721A1 (de) | 2006-05-04 | 2007-11-15 | Boehringer Ingelheim Internationalgmbh | Polymorphe |
PE20140960A1 (es) | 2008-04-03 | 2014-08-15 | Boehringer Ingelheim Int | Formulaciones que comprenden un inhibidor de dpp4 |
UY32030A (es) | 2008-08-06 | 2010-03-26 | Boehringer Ingelheim Int | "tratamiento para diabetes en pacientes inapropiados para terapia con metformina" |
KR20190016601A (ko) | 2008-08-06 | 2019-02-18 | 베링거 인겔하임 인터내셔날 게엠베하 | 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료 |
US20200155558A1 (en) | 2018-11-20 | 2020-05-21 | Boehringer Ingelheim International Gmbh | Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug |
US8865729B2 (en) | 2008-12-23 | 2014-10-21 | Boehringer Ingelheim International Gmbh | Salt forms of a xanthine compound |
TW201036975A (en) | 2009-01-07 | 2010-10-16 | Boehringer Ingelheim Int | Treatment for diabetes in patients with inadequate glycemic control despite metformin therapy |
AU2010323068B2 (en) | 2009-11-27 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin |
CN102946875A (zh) | 2010-05-05 | 2013-02-27 | 贝林格尔.英格海姆国际有限公司 | 组合疗法 |
MX2012014247A (es) | 2010-06-24 | 2013-01-18 | Boehringer Ingelheim Int | Terapia para la diabetes. |
US9034883B2 (en) | 2010-11-15 | 2015-05-19 | Boehringer Ingelheim International Gmbh | Vasoprotective and cardioprotective antidiabetic therapy |
MX366629B (es) | 2011-07-15 | 2019-07-17 | Boehringer Ingelheim Int | Quinazolinas sustituidas, su preparación y su uso en composiciones farmacéuticas. |
US9555001B2 (en) | 2012-03-07 | 2017-01-31 | Boehringer Ingelheim International Gmbh | Pharmaceutical composition and uses thereof |
JP6224084B2 (ja) | 2012-05-14 | 2017-11-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 糸球体上皮細胞関連障害及び/又はネフローゼ症候群の治療に用いるdpp−4阻害薬としてのキサンチン誘導体 |
WO2013174767A1 (en) | 2012-05-24 | 2013-11-28 | Boehringer Ingelheim International Gmbh | A xanthine derivative as dpp -4 inhibitor for use in modifying food intake and regulating food preference |
WO2015128453A1 (en) | 2014-02-28 | 2015-09-03 | Boehringer Ingelheim International Gmbh | Medical use of a dpp-4 inhibitor |
RU2609198C1 (ru) * | 2016-01-25 | 2017-01-30 | Закрытое Акционерное Общество "БИОКОМ" | Твердая лекарственная форма имипрамина немедленного высвобождения и способ ее получения |
US10155000B2 (en) | 2016-06-10 | 2018-12-18 | Boehringer Ingelheim International Gmbh | Medical use of pharmaceutical combination or composition |
KR102416406B1 (ko) * | 2019-09-24 | 2022-07-04 | 주식회사 종근당 | 티카그렐러의 산 부가염을 포함하는 안정화된 약학 조성물 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2554736A (en) | 1951-05-29 | Tertiary aminoalkyl-iminodibenzyls | ||
US2018410A (en) | 1933-12-11 | 1935-10-22 | Victor Chemical Works | Dentifrice preparation |
US2287699A (en) | 1940-02-15 | 1942-06-23 | Monsanto Chemicals | Stabilized dicalcium phosphate |
US3012852A (en) | 1956-06-06 | 1961-12-12 | Monsanto Chemicals | Stabilized calcium phosphates and process therefor |
DE1277222B (de) | 1965-12-22 | 1968-09-12 | Knapsack Ag | Verfahren zur Stabilisierung von Dicalciumphosphatdihydrat |
NL129434C (de) | 1966-03-12 | |||
US4128641A (en) | 1975-07-31 | 1978-12-05 | Hzi Research Center Inc. | Tetracyclic psychotropic drug |
DE2648061C2 (de) | 1976-10-23 | 1982-11-04 | Hoechst Ag, 6000 Frankfurt | Verfahren zum Stabilisieren von Di-calciumhydrogenphosphatdihydrat |
DE2741513A1 (de) | 1977-09-15 | 1979-03-22 | Benckiser Gmbh Joh A | Verfahren zum stabilisieren von calciumhydrogenphosphat-dihydrat gegen hydrolyse |
IE52274B1 (en) | 1980-12-12 | 1987-09-02 | Stauffer Chemical Co | A process of compacting fine particles of calcium phosphate and the compacts obtained thereby |
SE8103843L (sv) * | 1981-06-18 | 1982-12-19 | Astra Laekemedel Ab | Farmaceutisk mixtur |
US4743450A (en) | 1987-02-24 | 1988-05-10 | Warner-Lambert Company | Stabilized compositions |
US5004651A (en) | 1989-01-24 | 1991-04-02 | Abbott Laboratories | Stabilizing system for solid dosage forms |
GB8920693D0 (en) * | 1989-09-13 | 1989-10-25 | Nicholas Kiwi Pty Ltd | Non-effervescent ibuprofen compositions |
-
1991
- 1991-08-13 AT AT91202070T patent/ATE112491T1/de not_active IP Right Cessation
- 1991-08-13 EP EP91202070A patent/EP0475482B1/de not_active Expired - Lifetime
- 1991-08-13 DE DE69104453T patent/DE69104453T2/de not_active Expired - Lifetime
- 1991-08-13 DK DK91202070.8T patent/DK0475482T3/da active
- 1991-08-13 ES ES91202070T patent/ES2064887T3/es not_active Expired - Lifetime
- 1991-08-22 ZA ZA916661A patent/ZA916661B/xx unknown
- 1991-08-23 CA CA002049811A patent/CA2049811C/en not_active Expired - Fee Related
- 1991-08-27 AU AU83416/91A patent/AU643920B2/en not_active Expired
- 1991-08-29 IE IE305491A patent/IE65274B1/en not_active IP Right Cessation
- 1991-09-03 FI FI914147A patent/FI104361B/fi not_active IP Right Cessation
- 1991-09-11 NZ NZ239753A patent/NZ239753A/en not_active IP Right Cessation
- 1991-09-12 JP JP23322491A patent/JP3153577B2/ja not_active Expired - Fee Related
- 1991-09-12 KR KR1019910015896A patent/KR100196209B1/ko not_active IP Right Cessation
- 1991-09-12 PT PT98955A patent/PT98955B/pt not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
IE65274B1 (en) | 1995-10-18 |
CA2049811C (en) | 2002-11-05 |
KR920005978A (ko) | 1992-04-27 |
AU8341691A (en) | 1992-03-19 |
JPH0578236A (ja) | 1993-03-30 |
DK0475482T3 (da) | 1995-04-03 |
IE913054A1 (en) | 1992-02-25 |
NZ239753A (en) | 1992-10-28 |
AU643920B2 (en) | 1993-11-25 |
CA2049811A1 (en) | 1992-03-14 |
PT98955B (pt) | 1999-02-26 |
DE69104453D1 (de) | 1994-11-10 |
FI914147A0 (fi) | 1991-09-03 |
FI104361B (fi) | 2000-01-14 |
ATE112491T1 (de) | 1994-10-15 |
FI914147A (fi) | 1992-03-14 |
DE69104453T2 (de) | 1995-03-16 |
EP0475482B1 (de) | 1994-10-05 |
PT98955A (pt) | 1992-08-31 |
ES2064887T3 (es) | 1995-02-01 |
EP0475482A1 (de) | 1992-03-18 |
JP3153577B2 (ja) | 2001-04-09 |
KR100196209B1 (ko) | 1999-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA916661B (en) | Stabilized solid chemical compositions | |
KR0136279B1 (ko) | 일정수분을 함유하는 서방형 제제 | |
ES8800041A1 (es) | Un procedimiento para la produccion de una composicion farmaceutica de liberacion controlada de unidades individuales | |
IL67172A (en) | Derivatives of cis,endo-2-azabicyclo-(3.3.0)-octane-3-carboxylic acid,process for their preparation and pharmaceutical agents containing these compounds | |
UA27749C2 (uk) | Заміщені циклопропіламіно-1,3,5-триазини, їх оптичні ізомери, рацемічні суміші чи їх солі приєднання нетоксичних фармацевтично прийнятних кислот, що мають фармакологічну активність, спосіб їх одержання (варіанти) та фармацевтична композиція на їх основі | |
KR920006909B1 (ko) | 니트렌디핀을 함유하는 고상 약제의 제조 방법 | |
AU751575B2 (en) | Pharmaceutical levothyroxine preparation | |
MX9706062A (es) | FORMAS DE DOSIFICACION ORAL CONTENIENDO UN ANTIBIOTICO DE beta -LACTAMA. | |
MD1007C2 (ro) | 1,3-Oxatiolan,izomeri geometrici şi optici ai lui,amestecurile acestor izomeri, procedeu de obţinere a lor şi compoziţie farmaceutică care manifestă activitate antivirotică | |
US4906647A (en) | Stabilized pharmaceutical compositions | |
AU742382B2 (en) | Pharmaceutical preparation containing levothyroxine sodium | |
JPS5581596A (en) | Composition for determining creatine kinase | |
IL123185A0 (en) | Stable solid formulation of enalapril salt and process for preparation thereof | |
HU901428D0 (en) | Process for the preparation of 5-substituted 1,4-dihydro-4-oxo-naphthiridine-3-carboxylic acid derivatives | |
AU576386B2 (en) | 1h-indol-3-yl containing 1,3-dimethyl-1h-purine-2,6-diones | |
HU905725D0 (en) | Process for producing 1,4-disubstituted 5-aryl-carbamoyl-4(6)-oxo-6(4)-oxido-pyrimidine-betaine derivatives and anthelmintic preparatives containing these compounds as active substance | |
HU895241D0 (en) | Process for the preparation of substituted 1,3,5-triazin-trione derivatives and pharmaceutical compositions containing said compounds as active ingredient | |
MY137475A (en) | Chemical compounds. | |
ZA821036B (en) | Acesulfam-containing compositions,tablets on the basis thereof and process for the manufacture of these tablets | |
NO177484C (no) | Fremgangsmåte for fremstilling av et farmasöytisk preparat i form av myke kapsler | |
CA1070299A (en) | Stabilized solid form choline salicylate compositions | |
HUT56579A (en) | Process for producing 19-norprogesterone derivatives alkylated at 17/21 position, as well as pharmaceutical compositions comprising such compounds as active ingredient | |
JPS55122713A (en) | Tablet comprising antibacterial substance | |
ES8304924A1 (es) | Un procedimiento para la preparacion de nuevos derivados del acido glutamil-diaminopimelico que contiene una b-lactama. | |
ES8305722A1 (es) | Un procedimiento para la preparacion de nuevos derivados de tetrahidroisoquinolina (tetrahidroisoquinolina). |